MAR 20, 2015 10:44 AM PDT

Alzheimer's Drug Slows Cognitive Decline

WRITTEN BY: Judy O'Rourke
Biogen Idec Inc, Cambridge, Mass, says aducanumab, its new Alzheimer's drug under development shows signs of slowing the decline of a small number of patients with early indications and mild cases of the disease, according to The Boston Globe.

The company says its testing yielded "statistically significant" evidence the drug slows the decline of certain patients and reduced amyloid plaque in the brain (implicated in the development of Alzheimer's symptoms).
Beta-amyloid is chemically
Biogen says it plans to advance the drug compound to late-stage clinical trials, with FDA approval, and would start to enroll patients later this year.

The newspaper reports the company presented more detailed study results at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders.

Pharma giant Eli Lilly & Co is also working on an experimental drug for the disease.

More than 5 million Americans suffer from Alzheimer's. Treatments are available to help mitigate symptoms, but there is presently no cure for the disease.

[Source: The Boston Globe]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
SEP 07, 2020
Neuroscience
Researchers Identify 5 Kinds of Cat Owners
SEP 07, 2020
Researchers Identify 5 Kinds of Cat Owners
Conservationists have long been concerned about the number of animals caught by domestic cats. In the US alone, estimate ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
OCT 29, 2020
Clinical & Molecular DX
Skin Deep: A Novel Test for Parkinson's
OCT 29, 2020
Skin Deep: A Novel Test for Parkinson's
In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regi ...
NOV 13, 2020
Cell & Molecular Biology
Astrocytes are Star Players in the Brain
NOV 13, 2020
Astrocytes are Star Players in the Brain
As neurons fire, they enable us to think and move. They signal to one another where they meet at synapses, and at chemic ...
NOV 15, 2020
Neuroscience
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
NOV 15, 2020
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
Researchers from the University of Cambridge and University College London have found that a neurochemical known as nora ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...